SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : India Coffee House

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mohan Marette who wrote (3635)2/2/1999 1:46:00 PM
From: Mohan Marette  Read Replies (1) of 12475
 
Indian corporate results-FDC Ltd & Dr.Reddy's Laboratories.

Monday 1, Feb. '99
FDC LIMITED

--------------------------------------------------------------------------------


==========================================================================
FDC LIMITED
UNAUDITED FINANCIAL (PROVISIONAL)
FOR THE QUARTER & NINE MONTHS ENDED 31ST DECEMBER, 1998
(Rs in lacs)
==========================================================================
Unaudited (Audited)
------------------------------------- ---------
Particulars Quarter Quarter 9 Months 9 Months Prev. Acc.
ended ended ended ended yr Ended
31.12.98 31.12.97 31.12.98 31.12.97 31.03.98
==========================================================================
Net sales 2841 2359 10733 8292 11009
Other Income 42 12 94 35 56
Total Expenditure 2276 2048 8600 7257 9416
Gross Profit 607 323 2227 1070 1649
Interest-Net (17) (1) (75) - 3
Profit (after interest
but before Depreciation
and Tax) 624 324 2302 1070 1646
Depreciation 77 74 234 216 257
Provision for Taxation 140 50 540 175 276
Net Profit 407 200 1528 679 1113
Paid up Equity Share Capital *974 *974 *974 *974 *974
Reserves excluding
Revaluation Reserves - - - - 5786
===============================================================

* Represents After Forfeiture.
Notes :
1. The above results were taken on record at the meeting of the
Board of Directors held on 29.1.1999.
2. The above results are achieved as agitation and strike call by the
Federation of Medical Representatives Association of India (FMRAI),
in which some of the Company's Medical Representatives have participated.
==========================================================================

Monday 1, Feb. '99
Dr. REDDY'S LABORATORIES

--------------------------------------------------------------------------------


=================================================================================
Dr. REDDY'S LABORATORIES
UNAUDITED FINANCIAL RESULTS (PROVISIONAL) FOR THE THIRD QUARTER ENDED
31ST DECEMBER 1998
=================================================================================
(Figures Rs in lakhs) Unaudited
--------------------------------------
Quarter ended Nine months ended Year ended
------------------ -------------------
31.12.98 31.12.97 31.12.98 31.12.97 31.03.98
(Audited)
=================================================================================
Net Sales/income from
Operations (including
Excise Duty) 8965.00 7582.00 31339.66 24773.08 33162.00
Other Income 98.00 18.00 165.45 67.44 356.63
Total Income 9063.50 7600.00 31505.11 24840.52 33518.63
Total Expenditure
(Including Excise Duty) 7127.44 6164.41 24305.25 19457.44 26414.08
Profit Before Depreciation,
Interest & Tax 1936.06 1435.59 7199.86 5383.08 7104.55
Interest 286.40 175.08 751.22 595.43 888.08
Profit After Interest but
Before Depreciation & Tax 1649.66 1260.51 6448.64 4787.65 6216.47
Depreciation/Amortisation of
Brand Acquisition Cost 313.14 220.51 857.70 562.50 882.05
Provision for Taxation 0.00 0.00 425.00 500.00 450.00
Net Profit for the Period 1336.52 1040.00 5165.94 3725.15 4884.42
Extraordinary item-(Provision
for Export Recelvables)* 250.00 0.00 1250.00 0.00 0.00
Net Profit 1086.52 1040.00 3915.94 3725.15 4884.42
Paid-up Equity Share Capital 2648.73 2648.73 2648.73 2648.73 2648.73
Reserves (Excluding
Revaluation Reserves) - - - - 31438.03
Growth in Turnover 27.00
Growth in Profit Before 34.00
Depreciation, Interest & Tax 39.00
Growth in Net Profit for the Period
=================================================================================

Notes :
1. The above results have been taken on record by the Board of Directors of
the Company at its meeting held on 30th January 1999.
*2. This provision is in continuation of Rs 1000 lakhs already provided for
the first half of the current year towards current outstanding
receivables from CIS countries to elimiate country related financial risk.
=================================================================================





Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext